SIRT1, Polyphenols, and Endothelial Oxidants
SIRT1、多酚和内皮氧化剂
基本信息
- 批准号:7596514
- 负责人:
- 金额:$ 39.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-15 至 2014-01-31
- 项目状态:已结题
- 来源:
- 关键词:3-nitrotyrosine5&apos-AMP-activated protein kinaseAbbreviationsAccountingAcetyl-CoA CarboxylaseAdhesionsAdverse effectsAmino AcidsAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesAntioxidantsApoptosisApoptoticAreaArterial Fatty StreakAtherosclerosisAttentionBindingBlood VesselsCa(2+)-Calmodulin Dependent Protein KinaseCaM kinase I activatorCalciumCaloric RestrictionCattleCell Adhesion MoleculesCellsChronicCysteineDetectionDiabetes MellitusDiabetic mouseDietDown-RegulationEndothelial CellsEndotheliumExposure toFatty acid glycerol estersFunctional disorderGlucoseHistone DeacetylaseHumanHyperlipidemiaInflammationInsulin ResistanceInsulin-Dependent Diabetes MellitusIntercellular adhesion molecule 1LabelLaboratoriesLeukocytesLongevityLow Density Lipoprotein ReceptorManganese Superoxide DismutaseMass Spectrum AnalysisMediatingMetabolic syndromeMethodsMusMutant Strains MiceNitric OxideNitrogenNon-Insulin-Dependent Diabetes MellitusNonesterified Fatty AcidsOxidantsOxidation-ReductionOxygenPathway interactionsPeroxonitritePhosphotransferasesPost-Translational Protein ProcessingPredispositionProteinsRecombinantsResveratrolRoleSTK11 geneSignal TransductionSuperoxide DismutaseSuperoxidesTherapeutic EffectTissuesTyrosineUmbilical veinUp-RegulationVascular Cell Adhesion Molecule-1VasodilationWeightZincadenylate kinaseaortic archatherogenesisdimerfeedinghuman NOS2A proteinhuman NOS3 proteinimidazolecarboxamideloss of functionneurotensin mimic 1nitrationoxidant stressoxidationoxidized low density lipoproteinpolyphenolpreventprogramsred wineresponseribosidesarcoplasmic reticulum calcium ATPase
项目摘要
Increased oxidants are associated with insulin resistance, the metabolic syndrome, and a predisposition to
atherosclerosis. This laboratory has demonstrated that the increase in oxidants causes oxidative post-
translational modifications (OPTM) in key vascular cell proteins, including endothelial nitric oxide synthase
(eNOS), the sarcoplasmic reticulum calcium ATPase, p21ras, and manganese superoxide dismutase. These
OPTM including tyrosine nitration and cysteine sulfoxidation of specific amino acid residues have been
implicated in cellular dysfunction. In an example key to endothelial function, high glucose oxidizes the redox-
sensitive zinc thiolate that normally binds eNOS dimers, resulting in eNOS dysfunction. Our preliminary
studies have identified another potential oxidant target, sirtuin-1 (SIRT-1), a class III histone deacetylase that
is thought to be responsible for the increased life span caused by caloric restriction. Polyphenols, including
the red wine component, resveratrol, directly activate SIRT-1 and mimic the effects of caloric restriction, and
they have also recently been shown by others and us to reduce weight, hyperlipidemia, adhesion molecule
expression, oxidants, and atherosclerosis in fat-fed mice. We discovered that polyphenols stimulate AMP-
activated protein kinase (AMPK), and implicated AMPK in mediating improvements in hyperlipidemia and
atherosclerosis in diabetic mice. Together with other projects within this program, we now propose that
chronic oxidant stress associatedwith the metabolic syndrome can directly target and inactivate
SIRT1, contributing to the down-regulation of AMPK activity and endothelial dysfunction observed in
the metabolic syndrome. In addition, we propose that polyphenols stimulate SIRT1/LKB1/AMPK/
eNOS signaling to maintain endothelial function, decrease oxidants, and suppressadhesion
molecule expression, apoptosis, and atherogenesis. Our aims are to determine, 1) the role of down- and
up-regulation of SIRT1/LKB1/ AMPK/eNOS signaling in mediating the effect of oxidants and the response to
polyphenols, 2) what OPTM occur in SIRT-1 during exposure to oxidants, and 3) the role of SIRT1,LKB1
and eNOS in the therapeutic effect of polyphenols on inflammation, oxidants, and atherogenesis in fat-fed
mice.
氧化剂增加与胰岛素抵抗、代谢综合征和易患糖尿病的倾向有关
动脉粥样硬化。该实验室已证明氧化剂的增加会导致氧化后
关键血管细胞蛋白的翻译修饰 (OPTM),包括内皮一氧化氮合酶
(eNOS)、肌浆网钙 ATP 酶、p21ras 和锰超氧化物歧化酶。这些
OPTM 包括特定氨基酸残基的酪氨酸硝化和半胱氨酸磺化氧化
与细胞功能障碍有关。在内皮功能的一个关键示例中,高葡萄糖会氧化氧化还原-
敏感的硫醇锌通常与 eNOS 二聚体结合,导致 eNOS 功能障碍。我们的初步
研究发现了另一种潜在的氧化剂靶标,sirtuin-1 (SIRT-1),一种 III 类组蛋白脱乙酰酶,
被认为是热量限制导致寿命延长的原因。多酚类物质,包括
红酒成分白藜芦醇直接激活 SIRT-1 并模仿热量限制的效果,并且
最近其他人和我们也证明它们可以减轻体重、高脂血症、粘附分子
脂肪喂养小鼠的表达、氧化剂和动脉粥样硬化。我们发现多酚可以刺激 AMP-
激活蛋白激酶(AMPK),并暗示 AMPK 介导高脂血症和
糖尿病小鼠的动脉粥样硬化。与该计划中的其他项目一起,我们现在建议
与代谢综合征相关的慢性氧化应激可以直接靶向并失活
SIRT1,有助于下调 AMPK 活性和观察到的内皮功能障碍
代谢综合征。此外,我们认为多酚可以刺激 SIRT1/LKB1/AMPK/
eNOS 信号传导维持内皮功能、减少氧化剂和抑制粘附
分子表达、细胞凋亡和动脉粥样硬化。我们的目标是确定:1) 下层和下层的作用
SIRT1/LKB1/ AMPK/eNOS 信号传导上调介导氧化剂的作用及其反应
多酚,2) 暴露于氧化剂期间 SIRT-1 中会发生什么 OPTM,以及 3) SIRT1、LKB1 的作用
和 eNOS 在多酚对脂肪喂养的炎症、氧化剂和动脉粥样硬化的治疗作用中的作用
老鼠。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD A COHEN其他文献
RICHARD A COHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD A COHEN', 18)}}的其他基金
ID OF OXIDANT SENSITIVE CYSTEINE CONTAINING PROTEINS BY MASS SPECTROMETRY
通过质谱法鉴定含氧化剂敏感半胱氨酸的蛋白质
- 批准号:
8365499 - 财政年份:2011
- 资助金额:
$ 39.92万 - 项目类别:
PTM MAPPING IN HUMAN H-RAS UNDER OXIDATIVE STRESSES
氧化应激下人类 H-RAS 的 PTM 作图
- 批准号:
8365567 - 财政年份:2011
- 资助金额:
$ 39.92万 - 项目类别:
Aortic Stiffness and Hypertension in Obese Mice
肥胖小鼠的主动脉僵硬和高血压
- 批准号:
8484428 - 财政年份:2010
- 资助金额:
$ 39.92万 - 项目类别:
Redox Regulation of p21ras in Angiogenesis
p21ras 在血管生成中的氧化还原调节
- 批准号:
8294637 - 财政年份:2010
- 资助金额:
$ 39.92万 - 项目类别:
ID OF OXIDANT SENSITIVE CYSTEINE CONTAINING PROTEINS BY MASS SPECTROMETRY
通过质谱法鉴定含氧化剂敏感半胱氨酸的蛋白质
- 批准号:
8170862 - 财政年份:2010
- 资助金额:
$ 39.92万 - 项目类别:
Aortic Stiffness and Hypertension in Obese Mice
肥胖小鼠的主动脉僵硬和高血压
- 批准号:
8015829 - 财政年份:2010
- 资助金额:
$ 39.92万 - 项目类别:
Aortic Stiffness and Hypertension in Obese Mice
肥胖小鼠的主动脉僵硬和高血压
- 批准号:
8149954 - 财政年份:2010
- 资助金额:
$ 39.92万 - 项目类别:
Redox Regulation of p21ras in Angiogenesis
p21ras 在血管生成中的氧化还原调节
- 批准号:
8699256 - 财政年份:2010
- 资助金额:
$ 39.92万 - 项目类别:
Redox Regulation of p21ras in Angiogenesis
p21ras 在血管生成中的氧化还原调节
- 批准号:
8496102 - 财政年份:2010
- 资助金额:
$ 39.92万 - 项目类别:
相似国自然基金
晚期妊娠维持和抑制早产中cAMP信号活化PR的作用机制研究
- 批准号:81300507
- 批准年份:2013
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Elucidating the mechanism of erythropoietin (EPO) in mitigating Dry-AMD pathophysiology
阐明促红细胞生成素 (EPO) 缓解干性 AMD 病理生理学的机制
- 批准号:
10521937 - 财政年份:2022
- 资助金额:
$ 39.92万 - 项目类别:
Elucidating the mechanism of erythropoietin (EPO) in mitigating Dry-AMD pathophysiology
阐明促红细胞生成素 (EPO) 缓解干性 AMD 病理生理学的机制
- 批准号:
10521937 - 财政年份:2022
- 资助金额:
$ 39.92万 - 项目类别:
Dose Ranging study of the Effects of Alpha Acid on Oxidative Stress
α酸对氧化应激影响的剂量范围研究
- 批准号:
7472034 - 财政年份:2008
- 资助金额:
$ 39.92万 - 项目类别: